Cronos Group Reports 2021 Second Quarter Results

Amended agreement with Ginkgo Bioworks to accelerate commercialization of cultured cannabinoids Announced strategic investment in PharmaCann,…

Cronos Group Appoints Bob Madore as Chief Financial Officer

TORONTO, Aug. 06, 2021 (GLOBE NEWSWIRE) — Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group”…

Cronos Group Launches Delicious New Dual-Flavor Cannabis Gummies

SOURZ by Spinach™ gummies offer adult consumers a bold and juicy new cannabis edible featuring great tasting…

Cronos Group Announces Strategic Investment in PharmaCann, a Leading U.S. Cannabis Company

Investment is Expected to Position Cronos Group to Benefit from Rapid Growth in the U.S. Cannabis Market…

Cronos Group launches leading medical brand PEACE NATURALS™ in Israel

TORONTO and GAN SHMUEL, Israel, Oct. 05, 2020 (GLOBE NEWSWIRE) — Cronos Group Inc. (NASDAQ: CRON)…

Cronos Group Announces Expanded Leadership Structure to Drive Next Phase of Growth

TORONTO, Sept. 09, 2020 (GLOBE NEWSWIRE) — Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group”…

Cronos Group is a BUY, say Stifel analyst

Stifel analyst Andrew Carter upgraded Cronos Group to Buy from Hold with a price target of…

Cronos Group to Buy American Hemp CBD Assets for $300 Million

TORONTO, Aug. 02, 2019 (GLOBE NEWSWIRE) — Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group”…

Canopy And Cronos Are Exposed Come Earnings

Summary Growth of sales of recreational cannabis might be modest comparing Q1’19 to Q4’19. CRON is…